CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Tim Karl

OPENALEX: A5079586758↗ORCID: 0000-0001-9904-8482↗

Affiliations

Organizations

Camden and Campbelltown Hospitalsauthorship · AU Garvan Institute of Medical Researchauthorship · AU Neuroscience Research Australiaauthorship · AU Schizophrenia Research Instituteauthorship · AU St Vincent's Clinicauthorship · AU UNSW Sydneyauthorship · AU Western Sydney Universityauthorship · AU

Public evidence

5 connected articles

Behavioural effects of oral cannabidiol (CBD) treatment in the superoxide dismutase 1 G93 A (SOD1<sup>G93 A</sup>) mouse model of amyotrophic lateral sclerosis.2025 · Europe PMC Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer's disease.2022 · Europe PMC <i>In vivo</i> Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease.2017 · Europe PMC Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice2013 · PubMed Central Open Access Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice2012 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Tim Karl - Medical Cannabis Research Engine